Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;4(5):949-64.
doi: 10.2147/tcrm.s3145.

New advances in the treatment of Clostridium difficile infection (CDI)

Dennis D Hedge  1 , Joe D Strain, Jodi R Heins, Debra K Farver
Affiliations

New advances in the treatment of Clostridium difficile infection (CDI)

Dennis D Hedge et al. Ther Clin Risk Manag. 2008 Oct.

Abstract

Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. Although most mild to moderate cases of CDI continue to respond to metronidazole or vancomycin, refractory and recurrent cases of CDI may require alternative therapies. This review provides a brief overview of CDI and summarizes studies involving alternative antibiotics, toxin binders, probiotics, and immunological therapies that can be considered for treatment of acute and recurrent CDI in severe and refractory situations.

Keywords: Clostridium difficile; antibiotics; immunological therapy; probiotics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile Colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580–85. - PubMed
    1. Aboudola S, Kotloff KL, Kyne L, et al. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun. 2003;71:1608–10. - PMC - PubMed
    1. Acambis Acambis announces results from phase 1 trial of C. difficile vaccine [online] 2006. Accessed 29 February 2008. http://www.acambis.co.uk/default.asp?id=1457.
    1. Acambis Acambis concludes C. difficile vaccine formulation work on schedule and will commence proof-of-concept trial in 2008 [online] 2007. Accessed 29 February 2008. URL: http://www.acambis.co.uk/default.asp?id=2033.
    1. Acambis Clostridium difficile vaccine [online] 2008. Accessed 29 February 2008. URL: http://www.acambis.co.uk/default.asp?id=1938.